Modified and intact immunoglobulin preparations are available for therapeutic use. The administration of intravenous immunoglobulins (IVI G) gave positive results in Primary Immunodeficiency Syndromes (PIS) (prophylaxis of viral and bacterial diseases), in treatment of secondary immunodeficiencies (hematologic malignancies, bone marrow transplantation), and in some infections. Adverse reactions have been reported during IVIG infusions, but they are rarely serious and do not represent limiting conditions for a short or long term therapy. After the original observation in thrombocytopenic purpura, IVIG have been used as immune modulators in various autoimmune related disorders. Various mechanisms of action are proposed: blockade and down regulation of phagocytic function via Fc receptor, regulation of idiotype-anti idiotype network, suppression of idiotype synthesis, T-B cell interference towards antigen presentation, increase in suppressor lymphocytes, IVIG-cytokine interaction.
LuziG., PesceA.M., PaganelliR.Trattamento a lungo termine in pazienti con a/ipogammaglobulinemia con immunoglobuline per uso endovenoso.Immuno Clin Sper1987; 6: 219–31.
3.
Cunningham-RundlesC.Intravenous immunoglobulin: development as a therapy and unresolved issues In “Intravenous Immunoglobulin” Program and Abstracts - NIH Consensus Conference May 21-23, 1990; Bethesda- pag. 25–9.
4.
ImbachP., D'ApuzzoV., HirtA.High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.Lancet1981; 1: 1228–30.
5.
DwyerJ.M.Manipulating the immune system with immuno globulin.N Engl J Med1992; 326: 107–16.
6.
UnkelessJ.C.Function and heterogeneity of human Fc receptors for immunoglobulinG J Clin Invest1989; 83: 355–61.
AiutiF., LuziG.Deficienze immunologiche congenite ed acquisite. In “Trattato italiano di medicina interna” pp. 579–636 dir. P. Introzzi 1987 - USES Edizioni Scientifiche - Firenze
9.
BerkmanS.A., LeeM.L., GaleR.P.Clinical uses of intravenous immunoglobulins.Ann Intern Med1990; 112.
10.
EaveriS.V., DietrichG., HurezV., KazatchkineM.D.Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.Clin Exp Immunol1991; 86: 192–8.
11.
BallowM.Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases.Cancer (Suppl)1991; 68: 1430–6.
12.
GehaR.S.Regulation of the immune response by idiotypic-anti-idiotypic interactions.N Engl Med1981; 305: 25–8.
13.
KaveriS.V., KazatchkineM.D.Immunomodulation of autoimmune responses by IVIG treatment In: DominioniL., NydeggerU.E. eds. Intravenous immunoglobulins today and tomorrow. Proceedings - Satellite Symposium to the 11th Meeting of the International Society of Haematology, European and African Division, Basel (CH), 31 August-6 September, 1991 (International Congress and Sym. ser. No 189) London: Royal Soc. of Medicine Services Ltd.1992, pp. 3–9.
14.
BurdetteS., SchwartzR.S.Idiotypes and idiotypic networks.N Engl J Med1987; 317: 219–24
15.
DammaccoF., IodiceG., CampobassoN.Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin- Effects on circulating T cells subsets and PWM induced antibody synthesis in vitro.Br J Haematol1986; 62: 125–35.
16.
Intravenous immune globulin: prevention and treatment of diseases. NIH Consensus Development Conference. Consensus Statement, May 21-23, 1990. Vol. 8. No. 5. Bethesda, MD-Department of Health and Human Services, 1990.
17.
KimberleyR.P., SalmonJ.E., BusselJ.B., Euntz CrowM., Hilgart-nerM.W.Modulation of mononuclear phagocyte function by intravenous gammaglobulin.J Immunol1984; 132: 745–50.
18.
Delfraissy, TcherniaG., LaurianY., WallonC., GalanaudP., DormontJ.Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura.Br J Haematol1985; 60: 315–22.
19.
JungiT.W., NydeggerU.E.Proposed mechanisms of activation of intravenous IgG (IVIG) in autoimmune diseases.Transf Sci1992; 13: 267–90.
20.
RossiF., GuilbertB., TonnelleC.Idiotypic interactions between normal human polyspecific IgG and natural IgM antibodies.Eur J Immunol1990; 20: 2089–94.
21.
RossiF., DietrichG., KazatchkineM.D.Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responsesImmunol Rev1989; 110: 136–47.
22.
BerchtoldP., DaleG.L., TaniP., McMillanR.Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin.Blood1989; 74: 2414–17.
23.
SchwartzS.A.Intravenous immunoglobulin IVIG for the therapy of autoimmune disorders.J Clin Immunol1990; 10: 81–9.
24.
RossiF., SultanY., KazatchkineM.D.Anti-idiotypes against autoantibodies and alloantibodies to VIII: C (anti-haemo-philic factor) are present in therapeutic polyspecific normal immunoglobulins.Cin exp Immunol1988; 74: 311–16.
25.
JerneN.The immune system: a web of V-domains.New York: Academic Press, 1976.
26.
TannkersleyD.L., PrestonM.S., FinlaysonJ.S.Immunoglobulin G dimer: an idiotype-anti-idiotype complex.Mol Immunol1988; 25: 41–8.
27.
SultanY., RossiF., KazatchkineM.D.Recovery from anti VIII: C (antihemophilic factor) autoimmune disease is dependent on generation of antidiotypes againts anti-VIII: C autoantibodies.Proc Natl Acad Sci USA1987; 84: 828–31.
28.
BastaM., KirshbomP., FrankM.M., PriesL.F.Mechanism of therapeutic effect of high-dose intravenous immunoglobulin attenuation of acute, complement-dependent immune damage in a guinea pig model.J Clin Invest1989; 84: 1974–81.
Van DoornP.A., BrandA., StrengersP.F.W., MeulsteeJ., VermeulenM.High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.Nephrology1991; 40: 209–12.
32.
KleywegR.P., Van der MecheF.G.A., MeulsteeJ.Treatment of Guillain-Barrè syndrome with high-dose gammaglobulin.Nephrology1988; 38: 1639–41.
33.
LockwoodC.M.Therapeutic options in systemic vasculitis. In: ImbachP., ed. Immunotherapy with intravenous immunoglobulins.London: Academic Press, 1991; 297–306.
34.
HauptE., Rolandelli, BerdelliniG., RaffoA., MencoboniM.Inibitori del fattore VIII in pazienti non emofilici. Segnalazione di due casi e prospettive terapeutiche.Clin Ter1991; 138: 213–17.
35.
ChurchyardA., DayT., GraingerE., MastagliaF.L.Intravenous immunoglobulin therapy in the inflammatory neuropathies.Clin Exp Neurol1991; 28: 168–79.
Miceli SopoA., PesaresiM.A., StabileA.M., CastigliaS., StabileA.Intravenous immunoglobulin in the prophylaxis of neonata myasthenia gravis: report of a case.Ped Asthma All & Immunol1992; 6: 113–14.
TumiatiB., CasoliP., VenezianiM., RinaldiG.High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis.Arth and Rheum1992; 35: 1126–33.
42.
MarzushE., SchnaidtM., DietlJ., WiestE., HofstaetterC., GolzR.High-dose immunoglobulin in the antenatal treatment of neonatal alloimmune thrombocytopenia: case report and review.Brit J Obst Gynaecol1992; 99: 260–62.
43.
SilvermanE.D., LaxerR.M., GreenwaldM., GelfandE., ShoreA., SteinL.D., RoifmanC.M.Intravenous gammaglobulin therapy in systemic Juvenile rheumatoid arthritis.Arth and Rheum1990; 33: 1015–22.
44.
LusherJ.M., WarrierI.Use of intravenous gamma globulin in children and adolescents with idiopathic thrombocytopenic purpura and other immune thrombocytopenias.Am J Med1987; 83(S 4A): 10–16.
45.
ImbachP., WagnerH.P., BerchtoldW.Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.Lancet1985; 2: 464–8.
46.
HanadaT., SaitoK., NagasawaT.Intravenous gammaglobulin therapy for thromboneutropenic neonates of mothers with systemic lupus erythematosus.Eur J Haematol1987; 38: 400–4.
47.
KurtzebergJ., FriedmanH.S., KinneyT.R., ChaffeeS., Fallet-taJ.M.Treatment of platelet alloimmunization with intravenous immunoglobulin. Two case reports and review of the literature.Am J Med1987; 83(S 4A): 30–3
48.
GaedickeG., TellerW.M., KohneE., DopferR., Niethamlner D IgG therapy in systemic lupus erythematosus: two case reports.Blut1984; 48: 387–90.
49.
SilvermanE.D., LaxerR.M.Treatment of juvenile rheumatoid arthritis with intravenous gammaglobulin.Antibody therapy in contemporary medicine1989; 1: 1–3.
50.
ArsuraE.L., BickA., BrunnerN.G., NambaT., GrobD.High-dose intravenous immunoglobulin in the management of myastenia gravis.Arch Inst Med1986; 146: 1365–8.
51.
CookL., EowardJ.F., FoldsJ.D.Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis.J Clin Immunol1988; 8: 23–31.
52.
Miceli BopoS., PesaresiM.A., StabileA.M., CastigliaS., StabileA.Intravenous immunoglobulin in the prophylaxis of neonatal myasthenia gravis: a report of a case.Pediatric asthma, Allergy and Immulogy1992; 2: 113–4.
SoukopW., TschabitscherH.Gamm globulin therapie bei multipler scklerase (MS). Theoretische uberlegungen und erste klinische erfahrungen mit 7s-immunoglobulin in der MS-therapie.Wien Med Wochenschr1986; 136: 477–80.
VermeulenM., van der MecheF.G.A., SpeelmanJ.D., WeberA., BuschH.F.M.Plasma and gammaglobulin infusion in chronic inflammatory polyneuropathy.J Nephrol Sci1985; 70: 317–26.
57.
EleywegR.P., van der MecheF.G.A., MeulsteeJ.Treatment of Guillain-Barre’ syndrome with high-dose gammaglobulin.Nephrology1988; 38: 1639–41.
58.
Sugi SakiT., SchiwachiS., YonekuraM.High-dose intravenous gammaglobulin for membranous nephropathy, membrane-proliferative glomerulonephritis and lupus nephritis.Fed Proc1982; 41: 62.
59.
PallaR., CiranniC., PanichiV., BianchiA.M., ParriniM., GraziG.Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety.Clin Nephrol1989; 35: 98–104.
60.
Ching-YuangL., Hey-ChiH., HungC.Improvement of histological and immunological change in steroid and immunosuppressive drug resistant nephritis by high-dose intravenous gammaglobulin.Nephron1992; 62: 465.
61.
TomerY., ShoenfeldY.Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin.Clin Exp Immunol1992; 10: 391–3.
62.
BeckerH., MitropoulouG., HelmkeK.Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin.Klin Wochenschr1989; 67: 286–90.
SilvermanE.D., LaxerR.M., GreenwaldM.Intravenous gammaglobulin therapy in systemic juvenile rheumathoid arthritis.Arth and Rheum1990; 33: 1015–22
65.
TumiatiB., CasaliP., VenezianiM., RinaldiG.High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis.Arth and Rheum1992; 35: 1126–33.
66.
MorensD.M., AndersonL.J., HurwitzE.S.National surveillance of Eawasaki disease.Pediatrics1980; 65: 21–5.
67.
SchulmanST (ed.). Kawasaki disease (prooceedings of the Second International Kawasaki).
68.
ShulmanS.T.Kawasaki disease and IVIG: what's going on here? In: ImbachP., ed. Immunotherapy with intravenuos immunoglobulin.London: Academic Press1991; 261–8.
69.
LekovaE.S., JoffeL, GlodeM.P.Antigenic recognition by intravenuos gammaglobulin of selected bacteria isolated from throats of patients with Kawasaki syndrome.Pediatr Infect Dis1990; 9: 620–3.
70.
StirratG.M.Recurrent miscarriage I: definition and epidemiology.Lancet1990; 336: 670–3.
71.
CardH.J.A., ToderV., MashiachS., NebelL., SerrD.M.Recurrent miscarriage: a review of current concepts, immune mechanisms, and results of treatment.Obstet Ginecol Surv1990; 45: 657–5.
72.
LockwoodC.J., ReeceE.A., RomeroR., HobbinsJ.C.Antiphos-pholipidid antibody and pregnancy wastage.Lancet1986; 2: 742.
73.
UnanderA.M., NorbergR., HahnL., ArfosL.Anticardiolipin antibodies and complement in ninety women with habitual abortion.Am J Obstet Gynecol1987; 30: 601.
74.
NilsonI.M., AstetB., HednerU., BerezinD.Intrauterine death and circulating anticoagulant ('antithromboplastin').Acta Med Scan1975; 197: 153.
75.
HughesG.R.V.Vascular disease thrombosis, and recurrent abortion.Br Med J1988; 297: 700.
ScottJ.R., BranchD.W., KochenourN.K., WardK.Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization.Am J Obstet Gynecol1989; 159: 1055.
80.
WapnerR.J., CowchockF.S., ShapiroS.S.Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions.Am J Obstet Gynecol1989; 161: 1271–7.
81.
KatzV.L., ThorpJ.M., WatsonW.J., FowlerL., HeineR.P.Human immunoglobulin therapy for pre-eclampsia associated with lupus anticoagulant and anticardiolipin antibody.Obstet Ginecol1990; 76: 986–7.
